These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36440022)

  • 21. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
    Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
    Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis.
    Saito T; Fujisaki T; Aikawa T; Kampaktsis PN; Malik A; Briasoulis A; Takagi H; Wiley J; Slipczuk L; Kuno T
    Int J Cardiol; 2023 Oct; 389():131157. PubMed ID: 37433404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
    Harris J; Pouwels KB; Johnson T; Sterne J; Pithara C; Mahadevan K; Reeves B; Benedetto U; Loke Y; Lasserson D; Doble B; Hopewell-Kelly N; Redwood S; Wordsworth S; Mumford A; Rogers C; Pufulete M
    Health Technol Assess; 2023 May; 27(8):1-257. PubMed ID: 37435838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P2Y
    Gragnano F; Mehran R; Branca M; Franzone A; Baber U; Jang Y; Kimura T; Hahn JY; Zhao Q; Windecker S; Gibson CM; Kim BK; Watanabe H; Song YB; Zhu Y; Vranckx P; Mehta S; Hong SJ; Ando K; Gwon HC; Calabrò P; Serruys PW; Dangas GD; McFadden EP; Angiolillo DJ; Heg D; Valgimigli M;
    J Am Coll Cardiol; 2023 Feb; 81(6):537-552. PubMed ID: 36754514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2Y12 Inhibitor Monotherapy After Short DAPT in Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
    Galli M; Laudani C; Occhipinti G; Spagnolo M; Gragnano F; D'Amario D; Navarese EP; Mehran R; Valgimigli M; Capodanno D; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2024 Jul; ():. PubMed ID: 39054275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
    Kang J; Rizas KD; Park KW; Chung J; van den Broek W; Claassens DMF; Choo EH; Aradi D; Massberg S; Hwang D; Han JK; Yang HM; Kang HJ; Chang K; Ten Berg JM; Sibbing D; Koo BK; Kim HS
    Eur Heart J; 2023 Apr; 44(15):1360-1370. PubMed ID: 36883613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials.
    Giacoppo D; Matsuda Y; Fovino LN; D'Amico G; Gargiulo G; Byrne RA; Capodanno D; Valgimigli M; Mehran R; Tarantini G
    Eur Heart J; 2021 Jan; 42(4):308-319. PubMed ID: 33284979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
    Valgimigli M; Hong SJ; Gragnano F; Chalkou K; Franzone A; da Costa BR; Baber U; Kim BK; Jang Y; Chen SL; Stone GW; Hahn JY; Windecker S; Gibson MC; Song YB; Ge Z; Vranckx P; Mehta S; Gwon HC; Lopes RD; Dangas GD; McFadden EP; Angiolillo DJ; Leonardi S; Heg D; Calabrò P; Jüni P; Mehran R; Hong MK;
    Lancet; 2024 Sep; 404(10456):937-948. PubMed ID: 39226909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dual antiplatelet therapy after acute coronary syndrome or percutaneous coronary intervention: with what and for how long?].
    Darius H
    Internist (Berl); 2021 Nov; 62(11):1243-1252. PubMed ID: 34633479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review.
    Han YL
    Chin Med J (Engl); 2019 Jan; 132(2):197-210. PubMed ID: 30614864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.
    Obayashi Y; Watanabe H; Morimoto T; Yamamoto K; Natsuaki M; Domei T; Yamaji K; Suwa S; Isawa T; Watanabe H; Yoshida R; Sakamoto H; Akao M; Hata Y; Morishima I; Tokuyama H; Yagi M; Suzuki H; Wakabayashi K; Suematsu N; Inada T; Tamura T; Okayama H; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012004. PubMed ID: 35912647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De-escalation of antiplatelets after percutaneous coronary intervention: a Bayesian network meta-analysis of various de-escalation strategies.
    Khan SU; Khan MZ; Khan MS; Mahmood A; Kalra A; Kaluski E; Michos ED; Alkhouli M
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):209-215. PubMed ID: 32271872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P2y
    Yu Y; Pan D; Bai R; Luo J; Tan Y; Duan W; Shi D
    Front Cardiovasc Med; 2023; 10():1197161. PubMed ID: 37485257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.
    Gorog DA; Ferreiro JL; Ahrens I; Ako J; Geisler T; Halvorsen S; Huber K; Jeong YH; Navarese EP; Rubboli A; Sibbing D; Siller-Matula JM; Storey RF; Tan JWC; Ten Berg JM; Valgimigli M; Vandenbriele C; Lip GYH
    Nat Rev Cardiol; 2023 Dec; 20(12):830-844. PubMed ID: 37474795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCI.
    Greco A; Mauro MS; Capodanno D; Angiolillo DJ
    Rev Cardiovasc Med; 2022 Oct; 23(10):348. PubMed ID: 39077128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Li Y; Lei M; Yang Y; An L; Zhou H; Wang J; Zhao Z; Wang X; Nie S; Wang X; Hau WK; Xue Z
    Medicine (Baltimore); 2023 Jul; 102(27):e34153. PubMed ID: 37417626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: a meta-analysis.
    Gelbenegger G; Erari-Canyurt U; Grafeneder J; Jilma B; Lesiak M; Komosa A; de Caterina R; Postula M; Siller-Matula JM
    Vascul Pharmacol; 2021 Jun; 138():106858. PubMed ID: 33753284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial.
    Guimarães PO; Franken M; Tavares CAM; Silveira FS; Antunes MO; Bergo RR; Joaquim RM; Hirai JCS; Andrade PB; Pitta FG; Mariani J; Nascimento BR; de Paula JET; Silveira MS; Costa TAO; Dall'Orto FTC; Serpa RG; Sampaio FBA; Ohe LN; Mangione FM; Furtado RHM; Sarmento-Leite R; Monfardini F; Assis SRL; Nicolau JC; Sposito AC; Lopes RD; Onuma Y; Valgimigli M; Angiolillo DJ; Serruys PW; Berwanger O; Bacal F; Lemos PA
    EuroIntervention; 2023 Jul; 19(4):e323-e329. PubMed ID: 37306039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual Antiplatelet Therapy De-escalation Strategies.
    Sinnaeve PR; Adriaenssens T
    Am J Cardiol; 2021 Apr; 144 Suppl 1():S23-S31. PubMed ID: 33706987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis.
    Ho AC; Egolum U; Parker S; Dimmel J; Hawkins A; Ling H
    Clin Drug Investig; 2020 Sep; 40(9):799-808. PubMed ID: 32661914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.